Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02926092 · ClinicalTrials.gov registry record
Observational Natural History Study of Autosomal Dominant Retinitis Pigmentosa (adRP)
A clinical trial, sponsored by Shire.
- Terminated
- Registry status
- 1
- Enrollment target
NCT02926092: Clinical Trial study, sponsored by Shire.
NCT02926092 is a clinical trial that was terminated before completion, run by Shire. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02926092 was terminated before completion, sponsored by Shire.
- TERMINATED
- Registry status
- 1 participants
- Enrollment target
Study Summary
The purpose of this study is to gain an understanding of how adRP progresses over time in patients with misfolded rod opsin mutations.
Interventions
- DIAGNOSTIC_TEST Observation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2017-03-13 |
| Est. Completion | 2017-04-13 |
Why NCT02926092 stopped before completion
NCT02926092 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 1 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Observation is the first listed.
NCT02926092 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02926092 about?
NCT02926092 is a clinical study titled "Observational Natural History Study of Autosomal Dominant Retinitis Pigmentosa (adRP)". The purpose of this study is to gain an understanding of how adRP progresses over time in patients with misfolded rod opsin mutations.
What is the current status of trial NCT02926092?
This trial is currently terminated. The enrollment target is 1 participants. The study started on 2017-03-13. Estimated completion is 2017-04-13.
What interventions are being tested in trial NCT02926092?
The interventions under investigation include: Observation (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT02926092?
This trial is sponsored by Shire, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI